International Public Health Protection Initiative for Nicaragua and Latin America
Ensuring the quality of health services in a comprehensive and integrated way through the production and certification of biological medicines and health technology manufacturing for domestic and international development.
Create in Nicaragua a comprehensive system for training highly qualified personnel for high technologies industry.
Transfer of proven production technologies for immunobiologicals prepared.
Precise certification and quality control exercised by international organisations at all stages.
Strengthen the production capacity and regulation of health technologies
Strengthen the National Regulatory Authority of drugs and biologicals of Nicaragua.
Share experiences and skills with the countries of Central America and Latin America to promote health technology transfer, set in the South-South cooperation.
Certify the plant and production of biological drugs.
Improve manufacturing processes for health technology.
The creation of a biotechnology plant in Nicaragua is the first project developed by INNOVA Salutem, which includes the transfer of health technologies with the St. Petersburg's Scientific Research Institute of Vaccines and Sera, Russia.
To Nicaragua and Latin America it represents a great opportunity, because it will have the supply of quality vaccines at affordable prices, ensuring the minimum period for delivery of supplies abroad. Nicaragua will be a platform for technology transfer and innovation, because the capacity of qualified personnel efficiently ensure a quick implementation of these programs.
The production of biological drugs requires the formation of highly qualified human resources as: microbiologists, virologists specialist in drug surveillance etc. which are capable of ensuring medical supplies with quality, safety and efficacy for the welfare of the population, which must be based on evidence of Good Manufacturing Practices. For the training of human resources, there have been identified forming academic communities in the field of health programs that provide comprehensive specialized higher education.
The creation of the biotechnology plant in Nicaragua, is supported by the Vaccine Institute in St. Petersburg, producer and distributor of vaccines to Russia. This Russian institution produces influenza vaccine, among others.
In 2015 was founded the company SpbNIIVyS mixed together with the Nicaraguan Social Security Institute, which is named after the Russian scientist Mechnikov and was designed by specialists of the company "Technovation" of India. The first vaccine to be produced in Nicaragua is against influenza.
At the end of 2016 and beginning of 2017, there will be an infrastructure equipped with communication equipment and production lines to manufacture influenza vaccine, where Russia will supply antigens.
During the implementation of stage I, the National Regulatory Authority, of third level, will be created, which allows to pass the entire production cycle. By 2019 it is planned to start in Nicaragua the production of antigens for vaccine production and thus the production of biological will be completely taken.
For the construction of the biological production plant in Nicaragua and in order to maintain quality standards in compliance with national and international standards, it is necessary that the Pan American Health Organization / World Health Organization (PAHO / WHO) and international institutions as CECMED of Cuba, certify its construction and production thereof. Which must ensure that national health technology manufacturing is in accordance to compliance with good manufacturing practice and laboratory.
The Russian plant SpbNIIVS and the biotechnology plant in Nicaragua must be certified by the competent international bodies.
Implementation of plans consistent with the health technologies to be made, with the corresponding situation analysis and cost-benefit to the health system.
Advice and provide technical support to the National Drug Regulatory Authority on regulatory aspects and monitoring of product quality consistent with PAHO / WHO standards.
We are open for cooperation. Email us directly email@example.com or call us at +505 2254 5021.
Please subscribe to get a weekly update on our progress